Forest Investigative Site 1823 — Salisbury, North Carolina

Forest Investigative Site 1823 is a clinical research site located in Salisbury, North Carolina, United States 28144.

Crixeo Health Trust Score: 53/100 (POOR). This profile has not yet been claimed by the site owner.

Forest Investigative Site 1823 has participated in 2 clinical trials.

Therapeutic areas: Chronic Obstructive Pulmonary Disease.

Sponsors: AstraZeneca.

Sponsor Feasibility Report

Trust Score: 53/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Forest Investigative Site 1823?

Forest Investigative Site 1823 has a Crixeo Trust Score of 53/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Forest Investigative Site 1823 conducted?

Forest Investigative Site 1823 has 2 clinical trials on record. Their work covers Chronic Obstructive Pulmonary Disease.

Is Forest Investigative Site 1823 accredited by Crixeo Health?

Forest Investigative Site 1823 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Forest Investigative Site 1823?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.